What iResearch Atlanta does

iResearch Atlanta (also known as CenExel Decatur or CenExel iResearch Atlanta) is a clinical research facility located in Decatur, Georgia, within the Atlanta metropolitan area. Founded in 2010 and operating as part of the CenExel national network of clinical research sites, the company conducts Phase I through Phase IV therapeutic clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The facility occupies 27,000 square feet of dedicated research space with 40 inpatient beds and includes separate specialized units for pediatric, adult, and geriatric populations, enabling demographic-specific protocol execution.

The company's core offering is clinical trial conduct services, delivered by board-certified physicians and medical staff with over 200 years of collective clinical trial experience. Participants are recruited primarily through direct outreach (a dedicated phone line), a centralized study-search portal at cenexelclinicaltrials.com, and organic social media presence across Facebook, LinkedIn, Twitter, and Instagram. The facility's location within one block of MARTA bus and train transit supports participant accessibility in the Atlanta metro. Sponsors and CROs are targeted through direct business development sales outreach.

iResearch Atlanta generates revenue through professional services fees paid by pharmaceutical sponsors and CROs for contracted clinical trial execution, including patient recruitment, data collection, medical oversight, and regulatory compliance. Participant compensation is funded by sponsors as part of the overall trial budget. As a subsidiary within the CenExel network, the company benefits from shared branding, multi-site trial capabilities, and centralized patient recruitment infrastructure, while serving a horizontal market of pharmaceutical sponsors seeking qualified Phase I-IV research sites. No revenue figures, funding rounds, or ownership details beyond the CenExel parent relationship are publicly disclosed.

Name

iResearch Atlanta

Legal name

CenExel iResearch Atlanta

Website

https://iresearchatlanta.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

iResearch Atlanta is a Decatur, Georgia-based clinical research facility operating within the CenExel national network, conducting Phase I-IV clinical trials for pharmaceutical sponsors and CROs using dedicated pediatric, adult, and geriatric units and 40 inpatient beds.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Phase I-IV trials
• Clinical trial site
• Patient recruitment services
• Therapeutic research studies

Headquarters

HQ city

Decatur

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Services for Sponsors/CROs: Revenue generated from conducting clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The facility provides research services including patient recruitment, data collection, medical oversight, and regulatory compliance in exchange for contract fees.
2. Participant Compensation: Clinical trial participants receive compensation for their time and travel, which is funded by sponsors as part of the overall trial budget.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

iResearch Atlanta (CenExel Decatur) is a clinical research facility that conducts Phase I-IV therapeutic clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The site recruits and enrolls clinical trial participants in the Atlanta metropolitan area and delivers inpatient monitoring, medical oversight, data collection, and regulatory compliance through a 27,000 sq ft facility with 40 inpatient beds and dedicated pediatric, adult, and geriatric units. Participants volunteer in exchange for compensation for time and travel, while sponsors/CROs contract the facility to execute their drug development protocols.

Product overview

iResearch Atlanta (CenExel Decatur) is a clinical research facility that operates as part of the CenExel national network. The company offers a single unified offering centered on clinical trial participation services, providing participants access to innovative medicines and medical treatments while contributing to pharmaceutical research. The facility features dedicated pediatric, adult, and geriatric units with 40 inpatient beds across 27,000 sq ft of research space. Services are delivered by board-certified physicians with over 200 years of collective clinical trial experience.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Trial Services

Quantifiable outcome

• First-class medical care with board-certified physician oversight for every procedure

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• CenExelcoreStrategic or Co-development PartnerCenExel is the parent national network of research sites that includes iResearch Atlanta (CenExel Decatur). The network provides shared resources, branding, patient recruitment tools, and a centralized clinical trials portal (cenexelclinicaltrials.com) that drives participant inquiries to member sites. The partnership enables multi-site trial capabilities and shared best practices across the research network.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• ICON plc: Global CRO with extensive site network (including acquired PRA Health) that runs Phase I-IV trials across all major therapeutic areas. Comparable as a sponsor-facing research services provider, though vastly larger and broader in scope.
• PPD (Thermo Fisher Scientific): Global CRO now owned by Thermo Fisher, operating large site networks and dedicated clinical research units. Comparable on Phase I-IV clinical research services, with much greater geographic and therapeutic reach.
• Syneos Health: Biopharmaceutical services organization with both CRO and site-management (SiteSolutions) operations. Overlaps with iResearch Atlanta on Phase II-IV trial site execution and sponsor contract relationships.
• IQVIA: Largest global CRO with deep site relationships and dedicated Phase I clinic assets (formerly Quintiles). Competes for the same sponsor/CRO trial allocations but operates at significantly greater scale with broader service offerings.
• Medpace: Mid-to-large full-service CRO with integrated clinical trial site operations in select therapeutic areas. Operates more broadly as a CRO but overlaps with iResearch Atlanta on Phase II-IV trial execution and sponsor relationships.

Direct peers

• CTI Clinical Trial and Consulting Services: Multi-specialty CRO with dedicated clinical research units running Phase I-IV trials across therapeutic areas including rare disease and oncology. Comparable as a sponsor-facing trial services provider with site operations and Phase I capability.
• CenExel (other network sites, e.g., CenExel Atlanta, CenExel CNS): Sister facilities within the same CenExel parent network that conduct Phase I-IV clinical trials using the same operating model, branding, and centralized recruitment portal. Comparable in service offering, sponsor relationships, and operational structure.
• Clínica Research Atlanta / Optimal Clinical Research: Smaller independent clinical research sites in the Atlanta region conducting Phase I-IV trials for pharmaceutical sponsors. Comparable as regional competitors targeting the same metro participant pool and sponsor relationships.
• Atlanta Center for Clinical Research: Phase I clinical research site based in the Atlanta metro area conducting inpatient and outpatient trials for sponsors and CROs. Directly comparable as a similarly sized, regionally focused Phase I-IV research facility serving the same Atlanta catchment and sponsor base.

Regional players

• Emory University Clinical Trials Unit: Academic medical center clinical research program based in Atlanta that conducts sponsor-funded Phase I-IV trials across diverse therapeutic areas. Comparable on Phase I-IV capability and Atlanta metro footprint, though anchored in academic medicine rather than commercial research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/iResearchATL
• Facebookfacebook.com/iResearchATL
• LinkedInlinkedin.com/company/iresearchatlanta
• Instagraminstagram.com/cenexel_iresearchatl

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iResearch Atlanta